Ascidians: An invertebrate chordate model to study Alzheimer's disease pathogenesis

DMM Disease Models and Mechanisms

Volumn 3, Issue 5-6, 2010, Pages 377-385

  Virata, Michael J ^b   Zeller, Robert W ^a,b  

^a SAN DIEGO STATE UNIVERSITY   (United States)

^b SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SECRETASE; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; GAMMA SECRETASE; HOMOTAURINE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCIDIACEA; CIONA INTESTINALIS; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; EMBRYO; FERTILIZATION; GENE MUTATION; GENETIC CONSERVATION; LARVA; NERVOUS SYSTEM; NEUROPATHOLOGY; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; SENILE PLAQUE; TRANSGENIC ANIMAL;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ANIMALS, GENETICALLY MODIFIED; BEHAVIOR, ANIMAL; CONSERVED SEQUENCE; DISEASE MODELS, ANIMAL; EMBRYO, NONMAMMALIAN; HUMANS; LARVA; MOLECULAR SEQUENCE DATA; PROTEIN PROCESSING, POST-TRANSLATIONAL; SENILE PLAQUES; UROCHORDATA;

ANIMALIA; ASCIDIA; ASCIDIACEA; CAENORHABDITIS ELEGANS; CIONA INTESTINALIS; INVERTEBRATA;

EID: 77952148678     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.003434     Document Type: Article

References (52)

1. Brookmeyer, R., Johnson, E., Ziegler-Graham, K. and Arrighi, H. M. (2007). Forecasting the global burden of Alzheimer's disease. Alzheimers Dement. 3, 186-191. (Pubitemid 46825511)
2. Buckig, A., Tikkanen, R., Herzog, V. and Schmitz, A. (2002). Cytosolic and nuclear aggregation of the amyloid beta-peptide following its expression in the endoplasmic reticulum. Histochem. Cell Biol. 118, 353-360.
3. Buxbaum, J. D., Koo, E. H. and Greengard, P. (1993). Protein phosphorylation inhibits production of Alzheimer amyloid beta/A4 peptide. Proc. Natl. Acad. Sci. USA 90, 9195-9198.
4. Chambon, J. P., Soule, J., Pomies, P., Fort, P., Sahuquet, A., Alexandre, D., Mangeat, P. H. and Baghdiguian, S. (2002). Tail regression in Ciona intestinalis (prochordate) involves a caspase-dependent apoptosis event associated with ERK activation. Development 129, 3105-3114. (Pubitemid 34874285)
5. Chiang, H. C., Iijima, K., Hakker, I. and Zhong, Y. (2009). Distinctive roles of different {beta}-amyloid 42 aggregates in modulation of synaptic functions. FASEB J. 23, 1969-1977.
6. Chiang, P. K., Lam, M. A. and Luo, Y. (2008). The many faces of amyloid beta in Alzheimer's disease. Curr. Mol. Med. 8, 580-584.
7. Cloney, R. (1982). Ascidian larvae and the events of metamorphosis. Am. Zool. 22, 817-826.
8. Crowther, D. C., Kinghorn, K. J., Miranda, E., Page, R., Curry, J. A., Duthie, F. A., Gubb, D. C. and Lomas, D. A. (2005). Intraneuronal Abeta, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer's disease. Neuroscience 132, 123-135. (Pubitemid 40380720)
9. Crowther, D. C., Page, R., Chandraratna, D. and Lomas, D. A. (2006). A Drosophila model of Alzheimer's disease. Methods Enzymol. 412, 234-255.
10. De Jonghe, C., Esselens, C., Kumar-Singh, S., Craessaerts, K., Serneels, S., Checler, F., Annaert, W., Van Broeckhoven, C. and De Strooper, B. (2001). Pathogenic APP mutations near the gamma-secretase cleavage site differentially affect Abeta secretion and APP C-terminal fragment stability. Hum. Mol. Genet. 10, 1665-1671.
11. Delsuc, F., Brinkmann, H., Chourrout, D. and Philippe, H. (2006). Tunicates and not cephalochordates are the closest living relatives of vertebrates. Nature 439, 965-968. (Pubitemid 43292413)
12. Eckman, C. B., Mehta, N. D., Crook, R., Perez-tur, J., Prihar, G., Pfeiffer, E., Graff-Radford, N., Hinder, P., Yager, D., Zenk, B. et al. (1997). A new pathogenic mutation in the APP gene (I716V) increases the relative proportion of A beta 42(43). Hum. Mol. Genet. 6, 2087-2089.
13. Eriksen, J. L. and Janus, C. G. (2007). Plaques, tangles, and memory loss in mouse models of neurodegeneration. Behav. Genet. 37, 79-100.
14. Fossgreen, A., Bruckner, B., Czech, C., Masters, C. L., Beyreuther, K. and Paro, R. (1998). Transgenic Drosophila expressing human amyloid precursor protein show gamma-secretase activity and a blistered-wing phenotype. Proc. Natl. Acad. Sci. USA 95, 13703-13708.
15. Geerts, H. (2004). NC-531 (Neurochem). Curr. Opin. Investig. Drugs 5, 95-100.
16. Gervais, F., Paquette, J., Morissette, C., Krzywkowski, P., Yu, M., Azzi, M., Lacombe, D., Kong, X., Aman, A., Laurin, J. et al. (2007). Targeting soluble Abeta peptide with Tramiprosate for the treatment of brain amyloidosis. Neurobiol. Aging 28, 537-547. (Pubitemid 46282205)
17. Gotz, J., Streffer, J. R., David, D., Schild, A., Hoerndli, F., Pennanen, L., Kurosinski, P. and Chen, F. (2004). Transgenic animal models of Alzheimer's disease and related disorders: histopathology, behavior and therapy. Mol. Psychiatry 9, 664-683. (Pubitemid 38932172)
18. Graham, A. (2004). Evolution and development: rise of the little squirts. Curr. Biol. 14, R956-958.
19. Greeve, I., Kretzschmar, D., Tschape, J. A., Beyn, A., Brellinger, C., Schweizer, M., Nitsch, R. M. and Reifegerste, R. (2004). Age-dependent neurodegeneration and Alzheimer-amyloid plaque formation in transgenic Drosophila. J. Neurosci. 24, 3899-3906. (Pubitemid 38544216)
20. Guntern, R., Bouras, C., Hof, P. R. and Vallet, P. G. (1992). An improved thioflavine S method for staining neurofibrillary tangles and senile plaques in Alzheimer's disease. Experientia 48, 8-10.
21. Haass, C., Lemere, C. A., Capell, A., Citron, M., Seubert, P., Schenk, D., Lannfelt, L. and Selkoe, D. J. (1995). The Swedish mutation causes early-onset Alzheimer's disease by beta-secretase cleavage within the secretory pathway. Nat. Med. 1, 1291-1296.
22. Hardy, J. and Selkoe, D. J. (2002). The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356. (Pubitemid 34790756)
23. Iijima, K., Liu, H. P., Chiang, A. S., Hearn, S. A., Konsolaki, M. and Zhong, Y. (2004). Dissecting the pathological effects of human Abeta40 and Abeta42 in Drosophila: a potential model for Alzheimer's disease. Proc. Natl. Acad. Sci. USA 101, 6623-6628.
24. Imai, J. H. and Meinertzhagen, I. A. (2007). Neurons of the ascidian larval nervous system in Ciona intestinalis: II. Peripheral nervous system. J. Comp. Neurol. 501, 335-352.
25. Jiang, D., Tresser, J. W., Horie, T., Tsuda, M. and Smith, W. C. (2005). Pigmentation in the sensory organs of the ascidian larva is essential for normal behavior. J. Exp. Biol. 208, 433-438.
26. Katsuyama, Y., Matsumoto, J., Okada, T., Ohtsuka, Y., Chen, L., Okado, H. and Okamura, Y. (2002). Regulation of synaptotagmin gene expression during ascidian embryogenesis. Dev. Biol. 244, 293-304.
27. Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W. and Glabe, C. G. (2003). Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486-489. (Pubitemid 36444329)
28. Klein, W. L., Stine, W. B., Jr and Teplow, D. B. (2004). Small assemblies of unmodified amyloid beta-protein are the proximate neurotoxin in Alzheimer's disease. Neurobiol. Aging 25, 569-580.
29. Lesne, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M. and Ashe, K. H. (2006). A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440, 352-357.
30. Link, C. D. (1995). Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA 92, 9368-9372.
31. Link, C. D. (2005). Invertebrate models of Alzheimer's disease. Genes Brain Behav. 4, 147-156.
32. Link, C. D., Taft, A., Kapulkin, V., Duke, K., Kim, S., Fei, Q., Wood, D. E. and Sahagan, B. G. (2003). Gene expression analysis in a transgenic Caenorhabditis elegans Alzheimer's disease model. Neurobiol. Aging 24, 397-413. (Pubitemid 36205048)
33. Marambaud, P. and Robakis, N. K. (2005). Genetic and molecular aspects of Alzheimer's disease shed light on new mechanisms of transcriptional regulation. Genes Brain Behav. 4, 134-146. (Pubitemid 40559140)
34. Maslow, K. (2008). 2008 Alzheimer's disease facts and figures. Alzheimers Dement. 4, 110-133.
35. McLaurin, J., Cecal, R., Kierstead, M. E., Tian, X., Phinney, A. L., Manea, M., French, J. E., Lambermon, M. H., Darabie, A. A., Brown, M. E. et al. (2002). Therapeutically effective antibodies against amyloid-beta peptide target amyloid-beta residues 4-10 and inhibit cytotoxicity and fibrillogenesis. Nat. Med. 8, 1263-1269.
36. Meinertzhagen, I. A., Lemaire, P. and Okamura, Y. (2004). The neurobiology of the ascidian tadpole larva: recent developments in an ancient chordate. Annu. Rev. Neurosci. 27, 453-485.
37. Mullan, M., Crawford, F., Axelman, K., Houlden, H., Lilius, L., Winblad, B. and Lannfelt, L. (1992). A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat. Genet. 1, 345-347.
38. Nalivaeva, N. N., Fisk, L. R., Belyaev, N. D. and Turner, A. J. (2008). Amyloid-degrading enzymes as therapeutic targets in Alzheimer's disease. Curr. Alzheimer Res. 5, 212-224.
39. Nixon, R. A., Cataldo, A. M. and Mathews, P. M. (2000). The endosomal-lysosomal system of neurons in Alzheimer's disease pathogenesis: a review. Neurochem. Res. 25, 1161-1172.
40. Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L. et al. (2006). Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J. Neurosci. 26, 10129-10140. (Pubitemid 44527407)
41. Shah, S., Lee, S. F., Tabuchi, K., Hao, Y. H., Yu, C., LaPlant, Q., Ball, H., Dann, C. E., 3rd, Sudhof, T. and Yu, G. (2005). Nicastrin functions as a gamma-secretase-substrate receptor. Cell 122, 435-447.
42. Svane, I. and Young, C. M. (1989). The ecology and behavior of ascidian larvae. Oceanography and Marine Biology: An Annual Review 27, 45-90.
43. Tsuda, M., Sakurai, D. and Goda, M. (2003a). Direct evidence for the role of pigment cells in the brain of ascidian larvae by laser ablation. J. Exp. Biol. 206, 1409-1417.
44. Tsuda, M., Kawakami, I. and Shiraishi, S. (2003b). Sensitization and habituation of the swimming behavior in ascidian larvae to light. Zoolog. Sci. 20, 13-22.
45. Wilquet, V. and De Strooper, B. (2004). Amyloid-beta precursor protein processing in neurodegeneration. Curr. Opin. Neurobiol. 14, 582-588.
46. Wu, Y. and Luo, Y. (2005). Transgenic C. elegans as a model in Alzheimer's research. Curr. Alzheimer Res. 2, 37-45.
47. Yoshioka, K., Miki, T., Katsuya, T., Ogihara, T. and Sakaki, Y. (1991). The 717Val-Ile substitution in amyloid precursor protein is associated with familial Alzheimer's disease regardless of ethnic groups. Biochem. Biophys. Res. Commun. 178, 1141-1146.
48. Zega, G., Thorndyke, M. C. and Brown, E. R. (2006). Development of swimming behaviour in the larva of the ascidian Ciona intestinalis. J. Exp. Biol. 209, 3405-3412.
49. Zeller, R. W. (2004). Generation and use of transgenic ascidian embryos. Methods Cell Biol. 74, 713-730. (Pubitemid 39752515)
50. Zeller, R. W., Virata, M. J. and Cone, A. C. (2006a). Predictable mosaic transgene expression in ascidian embryos produced with a simple electroporation device. Dev. Dyn. 235, 1921-1932.
51. Zeller, R. W., Weldon, D. S., Pellatiro, M. A. and Cone, A. C. (2006b). Optimized green fluorescent protein variants provide improved single cell resolution of transgene expression in ascidian embryos. Dev. Dyn. 235, 456-467.
52. Zhang, Y. W. and Xu, H. (2007). Molecular and cellular mechanisms for Alzheimer's disease: understanding APP metabolism. Curr. Mol. Med. 7, 687-696.